Yolanda Smith

Feature Writer

B.Pharm.

Pharmacy

Yolanda graduated with a Bachelor of Pharmacy at the University of South Australia and has experience working in both Australia and Italy. She is passionate about how medicine, diet and lifestyle affect our health and enjoys helping people understand this. In her spare time she loves to explore the world and learn about new cultures and languages.

Articles from Yolanda

What is the Half-Life of a Drug?

The elimination half-life of a drug is the time it takes for the concentration of the drug in the plasma or the total amount in the body to be reduced by 50%.

18 Jul 2016

Thyroiditis - Inflammation of the Thyroid Gland

Thyroiditis is a medical term to indicate inflammation of the thyroid gland, which can manifest as either hyperthyroidism or hypothyroidism.

18 Jul 2016

The Hygiene Hypothesis

The hygiene hypothesis is also sometimes referred to as the biome depletion theory, or the “old friends” theory, is a hypothesis that states that the cause of allergic disease may be immune intolerance resulting from inadequate exposure to parasites and microbes in childhood.

18 Jul 2016

Kallmann Syndrome Research

Kallmann syndrome is a medical condition characterized by idiopathic hypogonadotropic hypogonadism with anosmia. The scientific research into this condition has improved our understanding of it, and helped to improve the diagnostic and treatment recommendations for clinical practice.

18 Jul 2016

Kallmann Syndrome Treatment

The treatment of Kallmann syndrome typically involves hormone replacement therapy to normalize the sex hormone levels, so as to induce and maintain sexual development. Additional treatment may be required later in life if the individual wishes to start a family. Other factors, such as bone mineral density and the reduced sense of smell, should also be considered in the treatment of the condition.

18 Jul 2016

Kallmann Syndrome Epidemiology

Kallmann syndrome is considered to be a rare condition. Precise epidemiological data is lacking due to difficulty with the diagnosis of the condition and the acquisition of accurate data about the condition.

18 Jul 2016

Kallmann Syndrome Pathophysiology

Kallmann syndrome is also known as idiopathic hypogonadotropic hypogonadism with anosmia. It is a genetic condition that is caused by mutations in certain genes. Known mutations occur in genes such as ANOS1, FGFR1, PROKR2 or PROK2. Each of these genes plays a role in the development of certain areas of the fetal brain. Mutations in one of these genes account for up to 30% of cases, while the rest are considered to be caused by an unknown gene mutation.

18 Jul 2016

Kallmann Syndrome Signs and Symptoms

Kallmann syndrome, also known as idiopathic hypogonadotropic hypogonadism with anosmia, is a congenital condition that manifests as an abnormally low production of the hormones that are involved in sexual development. The hallmark symptoms of the condition include delay in or absence of puberty and an impaired or absent sense of smell.

18 Jul 2016

Kallmann Syndrome Diagnosis

The diagnosis of Kallmann syndrome, or idiopathic hypogonadotropic hypogonadism with anosmia, is made on the basis of clinical findings that suggest reduced or incomplete sexual maturation associated with hypogonadism, with reduced or absent sense of smell.

18 Jul 2016

Kallmann Syndrome

Kallmann syndrome is a medical condition marked by the delayed onset or absence of puberty, along with an impaired or absent sense of smell, known as hyposmia or anosmia respectively. It is a type of hypogonadotropic hypogonadism, which involves the deficient production of sex hormones responsible for secondary sexual development and maturation.

18 Jul 2016